Ion levels in ovarian carcinoma cells and the clinical and pathologic characteristicsALDH1 IHC score in tumor cells 1 (negative) Number Age (years old): 39 40?9 50?9 60?9 70 missing Histological subtype: Serous carcinoma Mucinous carcinoma Endometrioid carcinoma Clear cell carcinoma Mixed epithelial tumor Undifferentiated tumor Unclassified tumor and others FIGO Stage: I II III IV Not staged or mi
Was 0.507 year to 0.793 year.Huang et al. BMC Cancer (2015) 15:Page 4 ofFig. 1 ALDH1 expression in ovarian carcinoma cells and stromal cells. a A poor differentiated ovarian carcinoma showed negative immunostaining in tumor cells for ALDH1, while most of the stromal cells surrounding tumor cells were strongly positive (100?. b High magnitude was used in the same case in A, showing clear negative t
Red ancestry, the ubiquity of shared genealogical ancestry only tens of generations ago across Europe (and probably the globe, [7]) makes such sharing unsurprising, and assignment to distinct genealogical relationships not possible. What is informative about these likelihood sharing events from distant ancestors is that they provide a fine-scale view of an individual's distribution of ancestors (e
Lls and the staining was limited to the membrane and the cytoplasm (400?. e Tumor cells in a well differentiated ovarian carcinoma were all strongly positive while the stromal cells were negative (100?. f High magnitude of a part of figure (E) displayed strongly positive staining for ALDH1 in most of the epithelial tumor cells/hyperplasia epithelial cells (400?In the 232 patients, ALDH1 expression
Le disease in peripheral blood or bone marrow even when extremely sensitive immunophenotypic or molecular procedures are applied to look for residual illness. These sufferers are considered to possess achieved a minimal residual disease (MRD) unfavorable status.17-20 Numerous phase II trials have demonstrated that individuals achieving MRD negativity have a signif-icantly longer survival than peop
90 year, 0.580 year and 1.050 years, respectively. Furthermore, ALDH1 expression in ovarian carcinoma cells was significantly associated with betterOS and PFS by statistical analyses (p < 0.05, KaplanMeier method, Fig. 2a, b). Out of the 232 valid cases for survival analyses, ALDH1 expression in stromal cells was negative, low and high in 12 cases, 55 cases and 165 cases, respectively. The median
90 year, 0.580 year and 1.050 years, respectively. Furthermore, ALDH1 expression in ovarian carcinoma cells was significantly associated with betterOS and PFS by statistical analyses (p < 0.05, KaplanMeier method, Fig. 2a, b). Out of the 232 valid cases for survival analyses, ALDH1 expression in stromal cells was negative, low and high in 12 cases, 55 cases and 165 cases, respectively. The median
Was 0.507 year to 0.793 year.Huang et al. BMC Cancer (2015) 15:Page 4 ofFig. 1 ALDH1 expression in ovarian carcinoma cells and stromal cells. a A poor differentiated ovarian carcinoma showed negative immunostaining in tumor cells for ALDH1, while most of the stromal cells surrounding tumor cells were strongly positive (100?. b High magnitude was used in the same case in A, showing clear negative t

Our Network Sites Come and submit here also:

Bookmarking Your Sites
My Bookmarking Site
5 Submission - Social Bookmarking Site
Oscorp Solution - SOcial Bookmarking Site
Submitter Guru - Social Bookmarking Site
Search Engine - Social Bookmarking
SEO Manual Submission - Social Bookmarking Site
SOft Solutions India - Social Bookmarking Site
SEO Company Packages - Social Bookmarking Site
Social Bookmarking Sites